Subcutaneous Administration
A research delivery method in which a compound is injected into the subcutaneous tissue layer beneath the skin in animal models.
Definition
Subcutaneous (SC) administration is a parenteral delivery route in which a compound is injected into the subcutaneous tissue layer, located between the dermis and the underlying muscle fascia. In preclinical animal research, this route provides relatively consistent absorption kinetics compared to intramuscular or intraperitoneal routes, with gradual release from the subcutaneous depot into systemic circulation. Subcutaneous administration is used extensively in rodent pharmacology studies because the technique is straightforward, minimally invasive, and produces repeatable pharmacokinetic profiles suitable for systematic compound characterization.
Research Context
Subcutaneous administration is one of the most frequently used delivery routes in preclinical peptide research. Many published studies examining BPC-157, TB-500, Semax, Epithalon, and related research compounds use subcutaneous injection in rodent models. The subcutaneous route is selected in research contexts to achieve systemic compound exposure while minimizing procedural variability. Pharmacokinetic parameters established via subcutaneous administration form the basis for comparative studies across compound classes and dosing schedules in preclinical research programs.
Relevant Compounds
This term applies to the following research compound hubs.
Frequently Asked Questions
Explore the Research Library
Compound comparisons, research use cases, study indexes, and more. A complete reference for research-grade peptide science.